Related Experiment Video
Updated: Jan 31, 2026

Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
Safety and Efficacy of Microvascular Decompression for Trigeminal Neuralgia in the Octogenarian Population: Insights
Mohammadmahdi Sabahi1, Brandon Kaye2, Neel Balusa2
1Department of Neurological Surgery, Pauline Braathen Neurological Center, Cleveland Clinic Florida, Weston , Florida , USA.
Background And Objectives:
Although microvascular decompression (MVD) is the most effective long-term treatment for trigeminal neuralgia (TN), its risks make some neurosurgeons favor ablative procedures in elderly patients, despite their limited durability and higher risk of sensory deficits, sparking debate over the optimal approach. This retrospective analysis aims to evaluate the safety and efficacy of MVD in octogenarian patients with TN compared with younger patients.
Methods:
In this matched cohort analysis, a total of 280 patients were initially included, with 33 in the octogenarian group (≥80 years) and 247 in the nonoctogenarian group (<80 years). After 4:1 propensity score matching and excluding patients with previous MVD, 152 matched patients were selected for the main analysis.
Results:
Octogenarians were more likely to have lower body mass index (25.8 kg/m 2 vs 28.1 kg/m 2 , P = .0175) and a preoperative diagnosis of arrhythmias (15.2% vs 3.4%, P = .0237) but otherwise did not have any significant differences in medical comorbidities and the nature of TN or previous treatments. The only postoperative complications higher in octogenarians was new or worsened arrhythmia (6.1% vs 0%, P = .0460). Length of stay, readmission rates, reoperation, and medical and surgical complications did not have any significant difference between age groups. Notably, octogenarians experienced similar reductions in pain postoperatively, with similar improvements in Barrow Neurological Institute pain scores as nonoctogenarians.
Conclusion:
Octogenarians undergoing MVD for TN can achieve similar pain relief and postoperative outcomes to younger patients, despite a higher incidence of arrhythmia. Age alone should not preclude patients from receiving MVD; comprehensive evaluation of comorbidities and overall health is essential. MVD remains a viable option to improve quality of life in elderly patients with TN.
Insights
Microvascular decompression (MVD) offers effective trigeminal neuralgia (TN) pain relief for octogenarians, comparable to younger patients. Age is not a barrier; comprehensive health assessment is key for MVD suitability in elderly TN patients.
Area of Science:
- Neurosurgery
- Geriatric Medicine
- Pain Management
Background:
- Microvascular decompression (MVD) is the leading long-term treatment for trigeminal neuralgia (TN).
- Elderly patients often face a dilemma between MVD risks and less durable ablative procedures.
- This study compares MVD safety and efficacy in octogenarians versus younger patients.
Purpose of the Study:
- To evaluate the safety and efficacy of MVD in octogenarian patients (≥80 years) with TN.
- To compare outcomes between octogenarian and non-octogenarian TN patients undergoing MVD.
- To determine if age alone should influence MVD treatment decisions for TN.
Main Methods:
- A matched cohort analysis of 152 patients (33 octogenarians, 119 non-octogenarians) after propensity score matching.
- Exclusion of patients with prior MVD procedures.
- Comparison of preoperative characteristics, postoperative complications, and pain scores.
Main Results:
- Octogenarians had lower BMI and higher rates of preoperative arrhythmias.
- New or worsened arrhythmias were more common in octogenarians post-MVD (6.1% vs 0%).
- No significant differences in length of stay, readmission, reoperation, or other complications; similar pain relief and BNI scores were observed in both groups.
Conclusions:
- Octogenarians achieve comparable pain relief and postoperative outcomes with MVD for TN as younger patients.
- Arrhythmia is a notable postoperative complication in octogenarians, but overall outcomes remain similar.
- MVD is a viable treatment option for elderly TN patients, emphasizing individualized health assessments over age alone.
More Related Videos
Related Concept Videos
Sign Test for Matched Pairs
To conduct the sign test, we first calculate the differences in...
Analysis of Population Pharmacokinetic Data
The Anchoring-and-Adjustment Heuristic
Adjusting a Traverse
Survey Safety
Introduction to z Scores
z scores...

